210 likes | 223 Views
The Mediterranean School of Oncology. 56 th course. “Breast Cancer: from Epidemiology to Treatment ” Tunis, November 14, 2008. The Mediterranean School of Oncology An educational program of:. Consorzio Interuniversitario Nazionale per la Bio-Oncologia.
E N D
The Mediterranean School of Oncology 56th course “Breast Cancer: from Epidemiology to Treatment” Tunis, November 14, 2008
The Mediterranean School of Oncology An educational program of: Consorzio Interuniversitario Nazionale per la Bio-Oncologia
A Consortium of 15 Italian Universities 32 Full Professors, 55 Associate Professors 95 Scientists Ancona Ferrara Napoli Federico II Bologna Palermo Foggia Campus Biomedico Perugia 15 Cancer Clinics L’Aquila Catanzaro Milano Roma La Sapienza Chieti-Pescara Messina 12.000 sqm laboratories Teramo 2 Clinical Trial Offices Tumor Registry & Screening Programs www.cinbo.org
Two classes: 1. Italian residents 2. Foreign students (in English); All courses are accredited for ECM by Ministero della Salute, Italyor/and ESMO
10 600 Courses/year 8 Students/year 500 6 400 4 300 By December 2007: 47 courses >2500 students 2 200 0 0 2001 2002 2003 2004 2005 2006 2007
78 1954 75 72 35 30 25 20 15 10 5 Iraq USA Iran Italy Egypt Spain Bosnia Russia Israel Jordan Polland France Turkey Belgium Lithuania Germany Students by country
A large spectrum of cancer-related disciplines is covered, including: Molecular pathology & cancer genetics Onco-hemathology Medical oncology Radiation oncology Epidemiology/ biostatistics & clinical trials Cancer prevention & early diagnosis …..
Educational program • Postgraduate courses; • Training courses for health professionals • not frequently dealing with cancer patients; • Special topics for oncology nurses; • Master classes (residential, 2-weeks, with practical workshops) (Coming soon)
Scholarships • Available to candidates <30 years of age. • To apply for a scholarship: • a brief curriculum vitae; • a letter of presentation from an authorised • officer at the institute of affiliation. For information: http://www.mso.cinbo.org/
Diapo avaible a partir du 24 novembre prochaine: http://www.mso.cinbo.org/
A Consortium of 15 Italian Universities Ancona Milano Bologna Messina Campus Biomedico Napoli Federico II Catanzaro Palermo Chieti-Pescara Perugia Ferrara Roma La Sapienza Foggia Teramo L’Aquila
2008 – Course calendar March 3-4* Digestive cancers: from epidemiology to management March 28-29 Assessing and managing toxicities of molecularly targeted agents April 11-12 Highlights in management of gastrointestinal cancer May 9-10 Highlights in the management of prostate cancer June 13-14 Highlights in the management of NSCL cancer July 4-5 Highlights in the management of breast cancer September 26-27 Highlights in management of kidney cancer October 16-18 to be defined October 23-26to be defined November 7-8 to be defined November 28-29 Translational oncology: novel agents, approaches and targets *Cairo, Egypt
The “Formazione a Distanza in Oncologia” (FADO) Program A MSO/CINBO’s pilot project Consorzio Interuniversitario Nazionale per la Bio-Oncologia
FADO Program Designed to build or enhance professional knowledge, skills, and leadership in oncology and related disciplines through distance/online education & training. Teaching is made via satellite technology.
Target audience 1. Residents in medical oncology; 2. Ph.D. students (Dottorato di Ricerca) in oncology and related disciplines Consorzio Interuniversitario Nazionale per la Bio-Oncologia
FADO - Partners Organization & management: Technologies & services:
The Mediterranean Task Force for Cancer Control (MTCC) A MSO/CINBO’s pilot project Consorzio Interuniversitario Nazionale per la Bio-Oncologia
MTCC “An innovative project to raise awareness about cancer prevention and early detection via satellite technology” • courses • videoconferences; • lectures-seminars-lessons; To provide a forum for “distance learning discussion among CINBO member Universities and selected medical Institutions within the mediterranean area”
Launching Meeting of the Mediterranean Task Force for Cancer Prevention and Early Detection (MTCC) February 2nd, 2007 Rome, Italy With the participation of delegates from: Algeria Egypt France Greece Albania Croatia Jordan Lebanon Lybia Morocco Palestine Italy Portugal Syria Slovenia Spain Tunisia Turkey
Pioneer in signal transduction & cancer research Cloned human insulin gene licensed to Eli Lilly Discovered EGFR, HER2, FLK-1 etc Architect of targeted therapeutics One of the first scientists at Genentech Responsible for Herceptin – annual sales ca. >$1.0BN Discoveries led to SUTENT – projected sales >$1.0BN Director of Max Planck Society Founder of SUGEN Inc. NASDAQ listed in 1994 Sold to Pharmacia in 1997 for $670m Axel Ullrich